3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
55
Breast Neoplasms
29
Neoplasms
25
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Polycystic Ovary Syndrome
5
Pancreatic Neoplasms
5
Obesity
5
Lymphoma
5
Fatigue
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Lymphedema
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Stomach Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Skin Neoplasms
2
Sarcopenia
2
Recurrence
2
Rectal Neoplasms
2
Peripheral Nervous System Diseases
2
Neoplasm Metastasis
2
Melanoma
2
Interventions
Nivolumab
11
pembrolizumab
10
Ipilimumab
9
Cyclophosphamide
6
tebentafusp
5
Interleukin-2
4
Blood Specimen Collection
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
relatlimab
2
lenvatinib
2
cemiplimab
2
binimetinib
2
aflibercept
2
Surveys and Questionnaires
2
Dacarbazine
2
Crizotinib
2
Carmustine
2
Biopsy
2
ulixertinib
1
trametinib
1
sargramostim
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Exercise
×
1 year
×
Clear all
No trials found.